Effectiveness of the RTS,S/AS01E malaria vaccine in a real-world setting over 1 year of follow-up after the three-dose primary schedule: an interim analysis of a phase 4 study in Ghana, Kenya, and Malawi

Journal:
The Lancet Global Health
Published:
DOI:
10.1016/s2214-109x(25)00415-2
Affiliations:
16
Authors:
71
Go to article
Institutions Authors Share
Kenya Medical Research Institute (KEMRI), Kenya
8.000000
 0.16
Navrongo Health Research Centre (NHRC), GHS, Ghana
8.000000
 0.16
GlaxoSmithKline Belgium, Belgium
7.000000
 0.14
US Army Medical Research Directorate-Kenya (USAMRU-Kenya), Kenya
7.000000
 0.14
Malawi-Liverpool-Wellcome Trust Clinical Research Programme, Malawi
4.333333
 0.08
Kamuzu University of Health Sciences (KUHeS), Malawi
3.833333
 0.08
Kintampo Health Research Centre (KHRC), Ghana
3.833333
 0.08
Ghana Health Service (GHS), Ghana
3.833333
 0.08
Strathmore University, Kenya
2.000000
 0.04
GlaxoSmithKline R&D Bangalore, India
1.000000
 0.02
4Clinics, Belgium
1.000000
 0.02
University of Liverpool, United Kingdom (UK)
0.833333
 0.02
London School of Hygiene and Tropical Medicine (LSHTM), United Kingdom (UK)
0.333333
 0.01
Interested in Medical Microbiology?